HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 61-72 of 1,979
Drug study icon
CompletedNCT06462612

Lumateperone in the Treatment of people with Bipolar Mania

What is this study about?

Researchers compared Lumateperone and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Bentonville
BipolarityMedication studyAges 18–75
Countries
United States, Bulgaria, Romania, + 1 other
Sponsor
Intra-Cellular Therapies, Inc.
Drug study icon
Not Yet RecruitingNCT07654348

Efficacy and Mechanism of IPSRT for Bipolarity type II

Official study title

The Efficacy and Mechanism of Different Intervention Strategy for Bipolar II Disorder Patients With Rhythm Disturbance

This study isn't recruiting yet.

In Hangzhou
BipolarityMedication studyAges 18–60
Countries
China
Sponsor
First Affiliated Hospital of Zhejiang University
Behavioral study icon
Not Yet RecruitingNCT07570875

Evaluating the Impact of Ketogenic Therapy on Symptom Severity and Metabolic Side Effect Profile Among Individuals Living With Bipolarity in A Rural Southern Catchment Area

Official study title

Evaluating the Impact of Ketogenic Therapy on Symptom Severity and Metabolic Side Effect Profile Among Individuals Living With Bipolar Disorder in A Rural Southern Catchment Area - A Four-Arm Pilot Study

This study isn't recruiting yet.

In Montgomery
BipolarityInterventional studyAges 18+
Countries
United States
Sponsor
University of Alabama at Birmingham
Drug study icon
UnknownNCT06608641

Endoxifen for Bipolarity

Official study title

A Double-blind, Oral, Multiple-dose, Parallel, Randomized Study to Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients With Acute Mania Episodes With or Without Mixed Features

Current recruitment status is unconfirmed.

Multiple locations, including Cerritos
BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
Jina Pharmaceuticals Inc.
Drug study icon
CompletedNCT07046494

RAP-219 for Bipolarity

What is this study about?

Researchers compared RAP-219 and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
Rapport Therapeutics Inc.
Other study type icon
RecruitingNCT07589647

Targeted Suprachiasmatic Nucleus Electrical Stimulation for Bipolarity

Official study title

Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolar Disordercomorbid With Obesity

In Hangzhou
BipolarityPlacebo comparisonAges 18–45
Countries
China
Sponsor
First Affiliated Hospital of Zhejiang University
Drug study icon
WithdrawnNCT01932541

Latuda for Bipolarity

What is this study about?

Researchers are studying Latuda (Lurasidone) to find out how it affects manic symptoms in children and adolescents with bipolarity type II during a manic episode.

This study was withdrawn before enrollment.

In Boston
BipolarityMedication studyAges 6–17
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.